Score for the identification of osteoporosis in smokers (SIOS): its development using clinical, radiological and biochemical information

P. Rivera Ortega (Pamplona, Spain), J. González Gutiérrez (Pamplona, Spain), P. Restituto Aranguíbel (Pamplona, Spain), N. Varo Cenarruzabeitia (Pamplona, Spain), M. Colina Lorda (Pamplona, Spain), M. Calleja Canelas (Pamplona, Spain), M. Rodriguez Fraile (Pamplona, Spain), G. Bastarrika Alemán (Pamplona, Spain), A. Alcaide Ocaña (Pamplona, Spain), A. Campo Ezquibela (Pamplona, Spain), J. Zulueta Francés (Pamplona, Spain), J. Torres Tajes (Pamplona, Spain)

Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Session: New determinants of cardiovascular morbidity in COPD
Session type: Oral Presentation
Number: 5166
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Rivera Ortega (Pamplona, Spain), J. González Gutiérrez (Pamplona, Spain), P. Restituto Aranguíbel (Pamplona, Spain), N. Varo Cenarruzabeitia (Pamplona, Spain), M. Colina Lorda (Pamplona, Spain), M. Calleja Canelas (Pamplona, Spain), M. Rodriguez Fraile (Pamplona, Spain), G. Bastarrika Alemán (Pamplona, Spain), A. Alcaide Ocaña (Pamplona, Spain), A. Campo Ezquibela (Pamplona, Spain), J. Zulueta Francés (Pamplona, Spain), J. Torres Tajes (Pamplona, Spain). Score for the identification of osteoporosis in smokers (SIOS): its development using clinical, radiological and biochemical information. 5166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical, radiographic and therapeutic features of sarcoidosis in menopausal women
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


Clinical, radiological, and bacteriological features of tuberculosis (TB) in teenagers' initial treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 648s
Year: 2005

COVID-19 and obesity: specific clinical and laboratory features
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


Usefulness of the asthma predictive index in clinical practice: A systematic review and clinical epidemiological analysis
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012

Non CF-bronchiectasis: Aetiologic, clinical, radiological, microbiological and functional profile in a Greek population
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015


Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016



Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score.
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


How to predict COPD in a clinical setting
Source: Annual Congress 2005 - New strategies and drugs for smoking cessation
Year: 2005

Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


Clinical prediction guides in COPD, a real life evaluation
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019

BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015

Correlation of renal impairment with biochemical and radiological findings, and clinical outcome in COVID-19 pneumonia patients
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


The correlation between smoking and histopathological, radiological and clinical characteristics of lung cancer in Turkish female patients
Source: Eur Respir J 2005; 26: Suppl. 49, 156s
Year: 2005

The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015